These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 35913859

  • 1. Quantitative 99mTc-MDP SPECT/CT as an alternative to 18F-NaF PET/CT for objective assessment of osteoblastic bone metastases.
    Coskun N, Cagdas B, Yildirim N.
    Hell J Nucl Med; 2022; 25(2):132-137. PubMed ID: 35913859
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A, Mittra E, Dick DW, Gambhir SS.
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [Abstract] [Full Text] [Related]

  • 4. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [Abstract] [Full Text] [Related]

  • 5. Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
    Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC.
    Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, Hong RL, Yu CJ, Wang KL, Yang RS.
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [Abstract] [Full Text] [Related]

  • 7. Quantification evaluation of 99mTc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density.
    Huang K, Feng Y, Liu D, Liang W, Li L.
    Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
    [Abstract] [Full Text] [Related]

  • 8. Prospective study of Na[18F]F PET/CT for cancer staging in morbidly obese patients compared with [99mTc]Tc-MDP whole-body planar, SPECT and SPECT/CT.
    Usmani S, Ahmed N, Gnanasegaran G, Al Kandari F, Marafi F, Bani-Mustafa A, Musbah A, Jassem Almashmoum M, Van den Wyngaert T.
    Acta Oncol; 2022 Oct; 61(10):1230-1239. PubMed ID: 35862646
    [Abstract] [Full Text] [Related]

  • 9. 18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
    Rao L, Zong Z, Chen Z, Wang X, Shi X, Yi C, Zhang X.
    Medicine (Baltimore); 2016 Apr; 95(16):e3490. PubMed ID: 27100456
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 11. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.
    Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [Abstract] [Full Text] [Related]

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Nov; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Bone Metastases between 18F-NaF PET/CT, 18F-NaF PET, and Planar 99mTc-MDP Bone Scintigraphy in Patients with Newly Diagnosed Nasopharyngeal Carcinoma.
    Wang D, Yang Y, Zeng Z, Ye J, Guo C, Huang S, Guo X, Xiao J.
    Contrast Media Mol Imaging; 2022 Nov; 2022():5975338. PubMed ID: 35494210
    [Abstract] [Full Text] [Related]

  • 14. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Nov; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 15. A retrospective study of SPECT/CT scans using SUV measurement of the normal pelvis with Tc-99m methylene diphosphonate.
    Wang R, Duan X, Shen C, Han D, Ma J, Wu H, Xu X, Qin T, Fan Q, Zhang Z, Shi W, Guo Y.
    J Xray Sci Technol; 2018 Nov; 26(6):895-908. PubMed ID: 30103368
    [Abstract] [Full Text] [Related]

  • 16. 18 F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE.
    Papadakis GZ, Manikis GC, Karantanas AH, Florenzano P, Bagci U, Marias K, Collins MT, Boyce AM.
    J Bone Miner Res; 2019 Sep; 34(9):1619-1631. PubMed ID: 31116487
    [Abstract] [Full Text] [Related]

  • 17. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G, Srour S, Fried G, Drumea K, Kozlener E, Frenkel A, Israel O, Fogelman I, Kagna O.
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [Abstract] [Full Text] [Related]

  • 18. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.
    Langsteger W, Rezaee A, Pirich C, Beheshti M.
    Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
    [Abstract] [Full Text] [Related]

  • 19. 18F-Fluoride PET/CT and 99mTc-MDP SPECT/CT can detect bone cancer at early stage in rodents.
    Alves CRR, Faria DP, Carneiro CG, Garcez AT, Gutierrez VP, das Neves W, de Almeida NR, Cury Y, Chammas R, Brum PC.
    Life Sci; 2018 Aug 01; 206():29-34. PubMed ID: 29778807
    [Abstract] [Full Text] [Related]

  • 20. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.
    J Nucl Med; 2006 Feb 01; 47(2):287-97. PubMed ID: 16455635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.